ArticleEye (London, England)2025

Risk of audiologic side effects with teprotumumab treatment for thyroid eye disease: propensity matched analysis.

Jonathan C Markle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.